Takeda Pharma AG - Elvanse 20 mg, Kapseln | | 63023 | | 04 | | Elvanse 20 mg | | Kapseln | | N06BA12 | | Lisdexamfetamine | | 16.11.2016 | | |
| Composition | lisdexamfetamini dimesilas 20 mg corresp. dexamfetaminum 5.9 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 172 (flavum), E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.2721 mg. | Packungsbestandteile | | Capsules | | | | | | Principe actif | Concentr. |
---|
Lisdexamfetamini Dimesilas | 20 mg correspond Dexamfetaminum 5.9 mg |
| BAG: Principe actif | Concentr. |
---|
Lisdexamfetamini Dimesilas | 20 mg |
| | Agents auxilliaires | | informations additionels |
---|
(Flavum) | | | (Nigrum) | | | Carmellosum Natricum Conexum | | | Cellulosum Microcristallinum | | | E 171 | | color. | E 172 | | color. | Gelatina | | Kapselhülle | Kalii Hydroxidum | | | Lacca | | Drucktinte | Magnesii Stearas | | | Propylenglycol | | |
| |
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
---|
004 | 30 | 80.84 | 109.30 | A+ | LS | Oui |
|
|